Articles published in
Clin Res Hepatol Gastroenterol
Retrieve available abstracts of 13 articles: HTML format
Single Articles
May 2025
ZHAO J, Miao D Precision Oncology in Colorectal Cancer: An Anatomical Revolution Through
Molecular-Clinical Integration Across Colonic Subsites.
Clin Res Hepatol Gastroenterol. 2025 May 13:102613. PubMedAbstract available
VO-QUANG E, Gandini A, Taly V, Puig PL, et al Circulating tumor DNA: a new tool to predict recurrence and guide treatment of
colorectal cancer.
Clin Res Hepatol Gastroenterol. 2025 May 7:102611. PubMedAbstract available
March 2025
LI Y, Ma XM, Jia JG, Cao LY, et al Association between metabolic dysfunction-associated steatotic liver disease,
metabolic dysfunction subtypes and risk of colorectal cancer: A Prospective
Cohort Study.
Clin Res Hepatol Gastroenterol. 2025 Mar 15:102573. PubMedAbstract available
January 2025
DABOUT V, Mineur L, Tougeron D, Malicot KL, et al Induction triplet chemotherapy in patients with rectal adenocarcinoma and
synchronous metastases, an AGEO-FFCD study.
Clin Res Hepatol Gastroenterol. 2025;49:102514. PubMedAbstract available
November 2024
WANG J, Zhang X, Chen K, Liang Y, et al Optimization of endoscopic treatment strategies for R0 resection of rectal
neuroendocrine tumors smaller than 10 mm.
Clin Res Hepatol Gastroenterol. 2024;48:102469. PubMedAbstract available
October 2024
GOMEZ CIFUENTES JD, Berger S, Thrift AP, Ketwaroo G, et al Baylor College of Medicine (BCM) model predicts recurrence after mucosectomy of
colorectal lateral spreading tumors in European cohorts.
Clin Res Hepatol Gastroenterol. 2024;48:102460. PubMed
September 2024
JIN KM, Bao Q, Zhao TT, Wang HW, et al Comparing Baseline VAF in Circulating tumor DNA and Tumor Tissues Predicting
Prognosis of Patients with Colorectal Cancer Liver Metastases After Curative
Resection.
Clin Res Hepatol Gastroenterol. 2024 Sep 12:102464. PubMedAbstract available
August 2024
BRAGANCA S, Garcia AC, Alexandrino G, Oliveira AM, et al Validation of a novel BCM model for recurrence risk prediction after mucosectomy
of colorectal lateral spreading tumors in a European cohort.
Clin Res Hepatol Gastroenterol. 2024;48:102414. PubMedAbstract available
July 2024
AL-HAIDERI M Silymarin Suppresses Proliferation and PD-L1 expression in Colorectal Cancer
Cells and Increases Inflammatory CD8+ Cells in Tumor-Bearing Mice.
Clin Res Hepatol Gastroenterol. 2024 Jul 22:102425. PubMedAbstract available
KOURIE HR, Zouein J, Zalaquett Z, Chebly A, et al Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic
colorectal cancer.
Clin Res Hepatol Gastroenterol. 2024 Jul 13:102417. PubMedAbstract available
May 2024
CAZENEUVE N, Bouche O, Leger J, Borg C, et al Visceral fat and clinical outcome in patients receiving first-line chemotherapy
with bevacizumab for metastatic colorectal cancer.
Clin Res Hepatol Gastroenterol. 2024 May 22:102380. PubMedAbstract available
LU H, Wang H, Zhu L, Xu J, et al The impact of WeChat online education and care on the mental distress of
caregivers and satisfaction of elderly postoperative colorectal cancer patients.
Clin Res Hepatol Gastroenterol. 2024 May 6:102372. PubMedAbstract available
March 2024
RAN D, Xin C, Ma Y, Lu Y, et al Increased risk of colorectal adenomas with metabolic-associated fatty liver
disease components.
Clin Res Hepatol Gastroenterol. 2024;48:102302. PubMedAbstract available